Primers for specific detection of HTLV-II proviral DNA and their application
By designing specific primers and probes, combined with TaqMan qPCR and ddPCR technology, the problem of insufficient sensitivity and specificity of existing HTLV-II detection methods is solved, and high sensitivity and high accuracy are achieved for HTLV-II proviral DNA degree detection.
Patent Information
- Application Number
- CN202010059162.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-01-19
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2040-01-19
AI Technical Summary
The existing HTLV-II detection methods are cumbersome to operate, have low sensitivity and specificity, are prone to false positives, and cannot effectively detect extremely low content of HTLV-II genes.
Specific primers and probes were designed and synthesized for TaqMan qPCR and ddPCR detection technology, which can specifically detect HTLV-II proviral DNA in samples, improving the sensitivity and specificity of the detection.
It realizes stable detection of extremely low content HTLV-II genes, improves the precision and accuracy of the detection, reduces the false positive rate, and is suitable for qualitative and quantitative detection of various samples.
Smart Images

Figure CN113136453B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of molecular biological detection, and more specifically relates to the detection of HTLV-II proviral DNA. Background Art
[0002] HTLV-II is a type of human T-cell lymphotropic virus (HTLV), also known as human T-cell lymphotropic virus type II. It was first isolated from a patient with hairy cell leukemia in 1982 [1]. HTLV-II belongs to the mammalian type C virus of the oncovirus subfamily of the Retroviridae family. The genome is 8.95 kb long and appears as spherical particles under an electron microscope with a diameter of about 80 to 130 nm.
[0003] Human T-lymphotropic virus type II (HTLV-II) and human T-lymphotropic virus type I (HTLV-I) are closely related retroviruses with similar genomic structures and about 60–70% nucleotide sequence homology[2]. They have been under intensive study in recent years because of their association with tumorigenesis, neuropathology, and the ability to transform primary human T lymphocytes.
[0004] HTLV-II and HTLV-I have similar biological characteristics and common modes of transmission. Both can effectively transform and immortalize T lymphocytes in vitro and can survive in infected animals. However, there are significant differences in the clinical manifestations of the two viruses. HTLV-I can cause a variety of diseases, such as adult T-cell leukemia (ATL) [3,4], tropical spastic paraparesis (TSP) [5], multiple sclerosis (MS), and unexplained vasculitis (KW). In contrast, the pathogenicity of HTLV-II is much lower, with only a few cases reported as variant hairy cell leukemia and infectious diseases of the nervous system. In addition, HTLV-II infection is also associated with sporadic cases of myelopathy similar to HAM / TSP [6-8], but there is no clear relationship with the development of lymphoproliferative diseases. To date, the number of individuals who have been shown to be associated with specific diseases with HTLV-II is limited, so it is not possible to convincingly prove the exact etiological role of HTLV-II in human diseases epidemiologically.
[0005] HTLV-II is mainly prevalent among intravenous drug users in North America and Western Europe[9-11], and local infections can also be found in some American Indians and African pygmy tribes[12-14]. Similar to the multiple transmission routes of HTLV-I, HTLV-II can also be transmitted through infected blood, semen, vaginal fluid, rectal secretions, breast milk and organ transplantation, but the main way is through intravenous injection. Existing methods for detecting HTLV-II include peripheral blood or bone marrow cytology, serum HTLV-II antibody detection, virus particle and antigen detection and cerebrospinal fluid examination, but these methods are cumbersome to operate, have low sensitivity and specificity, and are prone to false positives.
[0006] The development of real-time fluorescence quantitative PCR (qPCR) technology has achieved a leap from qualitative to quantitative PCR. It has strong specificity, high sensitivity, simple and rapid detection methods, and can effectively detect low-copy target DNA fragments.
[0007] There are two methods of qPCR technology: dye method and TaqMan probe method. Dye method such as SYBR Green I dye can bind to the minor groove of double-stranded DNA and produce a fluorescent signal when excited. However, since any double strand can bind to it non-specifically to produce a non-specific signal, it will cause inaccurate results. The probe of the TaqMan probe method has a 5'-end fluorescent reporter group and a 3'-end quencher group. When the complete probe is excited by light, fluorescence resonance energy transfer will occur, so no signal can be detected; only when the DNA is replicated, the probe is hydrolyzed, and the reporter group and quencher group are separated, can the fluorescence be detected. Therefore, the strength of the fluorescent signal represents the number of templates. Since the number of released fluorescent groups and the number of PCR products are one-to-one, this technology can be used to accurately quantify the template. Although the difference in amplification efficiency between SYBR Green and TaqMan technology is not very large
[15] , TaqMan technology is more suitable for the detection and quantification of trace templates because of its higher specificity and sensitivity
[16] .
[0008] With the development of PCR technology, the third generation of PCR technology - digital PCR has achieved absolute quantification of samples. It can avoid the use of standards and use limiting dilution, end-point PCR and Poisson distribution to achieve direct quantification of nucleic acid concentration
[17] . Droplet-based digital PCR - droplet digital PCR (ddPCR) can achieve high-sensitivity detection of trace nucleic acids, with a sensitivity of up to a single nucleic acid molecule; it has excellent accuracy, precision and repeatability
[18] and can effectively distinguish samples with small concentration differences.
[0009] Real-time fluorescence quantitative PCR and digital PCR have high requirements for primers, especially non-specific reactions and primer dimers.
[0010] In this patent, we designed and synthesized specific primers / probes that only amplify the HTLV-Ⅱ pol gene sequence. This primer / probe can be used for both qPCR and ddPCR detection technologies. In addition, using this primer, we developed a set of TaqMan qPCR technology that can detect HTLV-Ⅱ provirus in samples. This detection method has strong specificity, high precision and accuracy, and can stably detect extremely low levels of HTLV-Ⅱ genes in various samples. Summary of the invention
[0011] The purpose of the present invention is to provide primers and / or probes specific for HTLV-II proviral DNA, as well as TaqMan qPCR and ddPCR methods that can be used to detect HTLV-II proviral DNA in a sample. This method is suitable for detecting whether HTLV-II proviral DNA exists in a sample.
[0012] The term "HTLV-II" is human T-lymphotropic virus type II, also known as human T-lymphotropic virus type II, which is a reverse transcription RNA virus. After the RNA of the virus infects the host, it is reverse transcribed into the corresponding DNA and integrated into the host genomic DNA.
[0013] The term "HTLV-II proviral DNA" refers to DNA that is reverse transcribed and integrated into the host genome after the HTLV-II virus infects the host cell. In the present invention, "HTLV-II gene fragment" or "HTLV-II fragment" can be used interchangeably to refer to a fragment of HTLV-II proviral DNA.
[0014] In one aspect, the present invention provides a primer pair for specifically detecting HTLV-II proviral DNA, the primer pair comprising a forward primer 5'-GCATCAAGCATTCTACCCATATAC-3' (SEQ ID NO: 1) and a reverse primer 5'-GAAGGTTAGGACAGTCTAGTAGATA-3' (SEQ ID NO: 2).
[0015] Another aspect of the present invention provides a primer and probe combination for specifically detecting HTLV-II proviral DNA, wherein the primer pair comprises a forward primer and a reverse primer, wherein the forward primer is 5'-GCATCAAGCATTCTACCCATATAC-3' (SEQ ID NO: 1), and the reverse primer is 5'-GAAGGTTAGGACAGTCTAGTAGATA-3' (SEQ ID NO: 2); the sequence of the probe is 5'-CTGGTCGAGAGAACC-3' (SEQ ID NO: 3), and the 5' end of the probe is labeled with a reporter fluorescent group, and the 3' end is labeled with a quencher group.
[0016] In some embodiments, the reporter fluorescent group labeled at the 5' end of the fluorescent probe is FAM, and the quencher group labeled at the 3' end is NFQ-MGB or TAMRA.
[0017] Another aspect of the present invention provides the use of the above primer pair or primer and probe combination in detecting HTLV-II proviral DNA in a sample.
[0018] Another aspect of the present invention provides use of the above primer pair or primer and probe combination in preparing a reagent for detecting HTLV-II proviral DNA in a sample.
[0019] In some embodiments, the detecting is by qPCR detection or by ddPCR detection.
[0020] As known to those skilled in the art, qPCR, also known as real-time quantitative PCR (Real-time Quantitative PCR), is to add a fluorescent group to the PCR reaction system, use the accumulation of fluorescent signals to monitor the PCR process in real time, and finally the unknown template can be quantitatively analyzed by the standard curve. In qPCR detection, the Ct value represents the cycle threshold, that is, the number of cycles experienced when the fluorescent signal in each reaction tube reaches the set threshold. Since the Ct value of each template is linearly related to the logarithm of the initial content of the template, the more the initial copy number, the smaller the Ct value. A standard curve can be made using a standard with a known initial content of a serial dilution, in which the abscissa represents the logarithm of the initial content and the ordinate represents the Ct value, or the ordinate represents the logarithm of the initial content and the abscissa represents the Ct value. As long as the Ct value of the unknown sample is obtained, the content of the sample can be calculated from the standard curve. qPCR is a mature technology in this field. When using existing instruments for qPCR detection, the Ct value of the sample can be directly obtained from the output results of the instrument.
[0021] In qPCR detection, fluorescent probes or fluorescent dyes can be used to obtain fluorescent signals. Common fluorescent probes can be, for example, TaqMan fluorescent probes, in which a specific fluorescent probe is added at the same time as a pair of primers during PCR amplification. The probe is an oligonucleotide with a reporter fluorescent group and a quencher fluorescent group labeled at both ends. When the probe is intact, the fluorescent signal emitted by the reporter group is absorbed by the quencher group; during PCR amplification, the 5'-3' exonuclease activity of the Taq enzyme cleaves and degrades the probe, separating the reporter fluorescent group and the quencher fluorescent group, so that the fluorescent monitoring system can receive the fluorescent signal, that is, for each DNA chain amplified, a fluorescent molecule is formed, achieving complete synchronization of the accumulation of fluorescent signals and the formation of PCR products. In some embodiments, the reporter fluorescent group can be, for example, FAM, and the quencher group can be, for example, NFQ-MGB or TAMRA. Those skilled in the art know that other reporter fluorescent genes and corresponding quencher fluorescent groups can also be used in the present invention.
[0022] In qPCR detection, fluorescent dyes can also be used to obtain fluorescent signals. For example, in the PCR reaction system, an excess of fluorescent dyes can be added. After the fluorescent dyes are non-specifically incorporated into the DNA double strands, fluorescent signals are emitted, while the dye molecules not incorporated into the strands will not emit any fluorescent signals, thereby ensuring that the increase in the fluorescent signal is completely synchronized with the increase in the PCR products. Commonly used fluorescent dyes can be, for example, SYBR fluorescent dyes, sulforhodamine (Texas Red), fluorescein isothiocyanate (FITC), hydroxyfluorescein (FAM), tetrachlorofluorescein (TET), JOE, VIC, ROX and NED, etc.
[0023] Digital PCR detection is also well known to those skilled in the art. In short, digital PCR (also known as single-molecule PCR) includes PCR amplification and fluorescence signal analysis. In the PCR amplification stage, the sample is diluted to the single-molecule level and evenly distributed to tens to tens of thousands of units for reaction. After the amplification is completed, the fluorescence signal of each reaction unit is collected. Finally, the original concentration or content of the sample is calculated by direct counting or Poisson distribution formula. Digital PCR includes microfluidic digital PCR and droplet digital PCR (ddPCR). Droplet digital PCR uses droplets as reaction units and uses an oil-in-water system to disperse the amplification system into tens of thousands or even millions of independent "amplification chambers", thereby dispersing the molecules in each template into independent amplification systems, each of which contains the enzymes, ions, primers and probes required for the reaction. During the amplification, each well performs a parallel amplification reaction. After the reaction is completed, the fluorescence signal of each oil droplet in a single reaction well is detected. Since the target molecule satisfies the Poisson distribution in the extremely dispersed system, the number of target molecules in the sample is calculated with the help of the number of positive oil droplets, achieving absolute quantification of the target sequence. Droplet digital PCR can be completed in a 96-well plate, and a single tube can contain tens of thousands of homogeneous reaction systems. It is a high-throughput detection method, and its fluorescent probe can use molecular beacons or Taqman probes. In the present invention, the fluorescent groups and fluorescent probes used for qPCR can also be used for ddPCR. Those skilled in the art are familiar with how to perform different digital PCR tests.
[0024] Another aspect of the present invention provides a kit for specifically detecting HTLV-II proviral DNA in a sample, the kit comprising the above primer pair, or the above primer and probe combination.
[0025] In some embodiments, the kit further includes any one or more reagents required for qPCR detection or ddPCR detection.
[0026] In some embodiments, any one or more reagents required for qPCR detection include one or more components selected from the following components: qPCR reaction solution (e.g., qPCR Master Mix (2X), which includes essential components such as enzymes required for qPCR reaction), water (e.g., nuclease-free high-purity water), and reference substances. The reference substances may be positive controls, such as HTLV-II provirus standards, such as plasmid DNA containing HTLV-II provirus DNA, and / or negative controls. The positive controls may also be plasmid DNA, genomic DNA, or cells with HTLV-II provirus DNA. The negative controls may be plasmid DNA, genomic DNA, cells, or water without HTLV-II provirus DNA.
[0027] In other embodiments, any one or more reagents required for ddPCR detection include one or more components selected from the following components: ddPCR reaction solution (eg, ddPCR Supermix), water (eg, nuclease-free high-purity water).
[0028] Another aspect of the present invention provides a method for detecting HTLV-II proviral DNA in a sample, comprising using the above-mentioned primer and probe combination to perform qPCR detection or ddPCR detection on DNA extracted from the sample, and qualitatively or quantitatively detecting whether HTLV-II proviral DNA is present in the sample based on the qPCR detection or ddPCR detection results. The DNA extracted from the sample can be, for example, genomic DNA.
[0029] Another aspect of the present invention provides a method for detecting HTLV-II proviral DNA in a sample, comprising the following steps:
[0030] (1) Extract DNA from samples;
[0031] (2) using a primer and probe combination that specifically amplifies HTLV-II proviral DNA, such as the primer and probe combination described above, to perform qPCR detection on HTLV-II proviral DNA standards and sample DNA, wherein the HTLV-II proviral DNA standards are samples of different given concentrations prepared with DNA containing HTLV-II proviral DNA fragments;
[0032] (3) The qPCR test results of HTLV-II proviral DNA standards were used to prepare a standard curve and fit a linear equation, where R 2 ≥0.99; and the accuracy (RE%) of each standard concentration is -75% to 150%, and the lowest concentration that can be stably detected is determined;
[0033] (4) Result determination: If an obvious amplification curve appears in the qPCR results of the sample DNA; and the Ct value of the qPCR of the sample DNA is less than the Ct value at the lowest concentration point, it is a positive result, that is, HTLV-II proviral DNA is present in the sample; if there is no obvious amplification curve, or if there is an obvious amplification curve but the Ct value is greater than the Ct value at the lowest concentration point of the standard curve, it is a negative result, that is, no HTLV-II proviral DNA is present in the sample.
[0034] In some embodiments, what is extracted is genomic DNA in the sample. The sample DNA may be sample genomic DNA. Methods for extracting genomic DNA from a sample are well known in the art, for example, genomic DNA may be extracted using a DNA extraction kit.
[0035] In some embodiments, when preparing the standard curve in the above step (3), the Ct value of the HTLV-II proviral DNA standard is used as the ordinate (Y), and the logarithm of the DNA concentration of the HTLV-II proviral DNA standard is used as the abscissa (X), and a linear equation is fitted.
[0036] In some embodiments, the HTLV-II proviral DNA standard comprises at least 6 samples of different given concentrations prepared with DNA containing HTLV-II proviral DNA fragments. The number of HTLV-II proviral DNA standards can be 6, 7, 8 or more. The HTLV-II proviral DNA standard can be prepared, for example, by mixing plasmid DNA containing HTLV-II proviral DNA fragments with water.
[0037] When fitting the standard curve, such as R 2 If the accuracy of the concentration of each standard does not meet the above requirements, satisfactory fitting results can be obtained by repeating the experiment, or re-preparing the DNA standard, or using a DNA standard of a different concentration. The fitting of the standard curve and the method of obtaining a satisfactory fitting result are well known to those skilled in the art.
[0038] The highest concentration point refers to the highest limit of the concentration that can be stably detected by the above method, which can also be called the upper detection limit or the upper quantitative limit in the present invention. The lowest limit of the concentration that can be stably detected is the lowest concentration point, which can also be called the lower detection limit or the lower quantitative limit in the present invention.
[0039] The method for judging whether an obvious amplification curve appears is well known to those skilled in the art. For example, when the curve in the ΔRn vsCycle mode is S-shaped, it can be determined that an obvious amplification curve appears.
[0040] In some embodiments, the qPCR reaction system is 10 μL of PCR Master Mix (2×), 1 μL of primers / probes (20×) for specific amplification of HTLV-II proviral DNA, and 9 μL of DNA sample + nuclease-free high-purity water. The DNA sample can be sample DNA, DNA standard, or other control, negative control, or quality control.
[0041] In some embodiments, the qPCR reaction is performed by first activating UDG at 50°C for 2 min, then activating DNA polymerase at 95°C for 10 min, and then performing 40 PCR reactions according to the following parameters: 95°C for 15 seconds, and 60°C for 1 min. In some embodiments, the qPCR reaction is performed on an Applied Biosystems ABI 7500 Real Time PCR instrument.
[0042] The present invention also provides a ddPCR method for detecting HTLV-II proviral DNA in a sample, comprising the following steps:
[0043] (1) Extracting DNA from samples;
[0044] (2) performing ddPCR testing on the sample DNA using a primer and probe combination that specifically amplifies HTLV-II proviral DNA, such as the primer and probe combination described above;
[0045] (3) Reading the fluorescence signal and performing analysis to quantify the HTLV-II proviral DNA copy number; preferably, the HTLV-II proviral DNA copy number result can be read on ddPCR QuantaSoft.
[0046] In some embodiments, the result determination may also be quantitative detection of HTLV-II proviral DNA in the sample, or may further include quantitative detection of HTLV-II proviral DNA in the sample. The quantitative detection may include, for example, determining the concentration of HTLV-II proviral DNA in the sample DNA based on the Ct value of the sample DNA and the fitted standard curve.
[0047] In the present invention, the sample can be an organ, tissue, whole blood, cell or body fluid sample.
[0048] In the present invention, the sample can be derived from humans or any animals, such as mice, rats, rabbits, monkeys and the like.
[0049] In some embodiments, the methods of the invention are performed in vitro.
[0050] In some embodiments, the methods of the invention are non-diagnostic, for example, they can detect the presence of HTLV-II proviral DNA in a biological product such as a vaccine.
[0051] In the present application, the terms "HTLV-II positive", "containing HTLV-II proviral DNA", "infected with HTLV-II" or similar expressions refer to cells infected with HTLV-II, whose genomic DNA contains HTLV-II proviral DNA, or tissues and organs containing these cells.
[0052] The present invention provides a new HTLV-II detection method, which uses real-time fluorescence quantitative PCR (qPCR) or ddPCR technology to detect HTLV-II proviral DNA fragments integrated into the host genome, and provides specific primers and / or probes for the DNA fragments. The primers, probes and methods of the present invention can greatly improve the sensitivity and specificity of detecting HTLV-II in samples, and can be used to track and qualitatively or quantitatively detect HTLV-II proviral DNA in samples, and to detect whether the sample is infected with human HTLV-II virus, avoiding the shortcomings of existing HTLV-II detection methods. Sequence Listing <110> Shanghai Essar Biotechnology Co., Ltd. <120> Primers for specific detection of HTLV-II proviral DNA and their application <160> 3 <170> SIPOSequenceListing 1.0 <210> 1 <211> twenty four <212> DNA <213> Artificial Sequence <400> 1 gcatcaagca ttctacccat atac 24 <210> 2 <211> 25 <212> DNA <213> Artificial Sequence <400> 2 gaaggttagg acagtctagt agata 25 <210> 3 <211> 15 <212> DNA <213> Artificial Sequence <400> 3 ctggtcgaga gaacc 15 BRIEF DESCRIPTION OF THE DRAWINGS
[0053] Figure 1 It is a simple experimental process of TaqMan-qPCR.
[0054] Figure 2 This is a diagram of the construction of a plasmid DNA containing an HTLV-II fragment.
[0055] Figure 3 It is the amplification curve of qPCR detection of standard concentration samples using HTLV-II specific primers / probes.
[0056] Figure 4 This is a standard curve graph. In the figure, the standard curve uses the Ct value of each standard concentration sample as the ordinate (Y), and the logarithm of the concentration of the standard concentration sample as the abscissa (X). The values of the abscissa have been log-converted, but are still indicated by the original concentration value of the standard concentration sample.
[0057] Figure 5 It is the amplification curve diagram for precision and accuracy verification.
[0058] Figure 6 It is the sensitivity verification amplification curve.
[0059] Figure 7 It is the dilution linear amplification curve.
[0060] Figure 8 It is the amplification curve diagram of specificity verification.
[0061] Fig. 9 Figure 2. HTLV-II ddPCR detection results.
[0062] The technical solution of the present invention is further described in detail below through embodiments and in conjunction with the accompanying drawings, but the present invention is not limited to the following embodiments.
[0063] Example 1 Detection of HTLV-II proviral DNA using Taqman qPCR method
[0064] The qPCR experimental methods in this example are all Taqman qPCR methods, and the sequences mentioned are all expressed from the 5' end to the 3' end.
[0065] 1. Experimental Materials and Instruments
[0066] 1.1 Primer design
[0067] Primers and fluorescently labeled probes were designed and synthesized based on the pol gene sequence of human HTLV-II. The primer information is shown in Table 1 below:
[0068] Table 1 Primer design related information
[0069] Primer name HTLV-II Gene ID 1491941 Forward primer sequence 5'-GCATCAAGCATTCTACCCATATAC-3' Reverse primer sequence 5'-GAAGGTTAGGACAGTCTAGTAGATA-3' Probe sequence 5'-CTGGTCGAGAGAACC-3'
[0070] The 5' end of the probe is labeled with a reporter fluorescent group FAM, and the 3' end is labeled with a quencher group NFQ-MGB.
[0071] 1.2 Construction of plasmid DNA
[0072] A 200 bp fragment of the HTLV-II Pol gene was cloned into the pUC57 vector to obtain a plasmid DNA containing the HTLV-II fragment, which was used as a standard. The cloning sites were XbaⅠ and BamHI. The construction diagram is shown in Figure 2 The standard was prepared as a lyophilized powder for later use.
[0073] Dilution of plasmid DNA: Take 4 μg of the lyophilized powder of the above plasmid DNA standard, centrifuge it instantaneously, add 10 μL of DEPC-water, and prepare it into a 0.4 μg / μL stock solution, and store it at -80℃. Take 10 μL of the stock solution, add 10 μL of water, and prepare it into a 0.2 μg / μL working solution for use.
[0074] 1.3 Consumables and instruments used in the experiment
[0075] Consumables and instruments are shown in Table 2:
[0076] Table 2 Consumables and instrument information
[0077]
[0078] 2. Experimental Methods
[0079] In the following experiment, a standard curve was prepared with plasmid DNA containing HTLV-II fragments to establish a detection method for identifying whether various samples are infected with HTLV-II. This method was used to perform comprehensive methodological validation of the standard curve and quantitative range, accuracy and precision, dilution linearity, specificity, etc. The experimental process is shown in the attached Figure 1 .
[0080] 2.1 Fluorescence quantitative PCR reaction conditions
[0081] Taqman-qPCR method was used, plasmid DNA was used as template, and Universal PCR Master Mix (2X), human HTLV-II specific primers and fluorescently labeled probes were used to complete the qPCR reaction on an Applied Biosystems ABI7500 Real Time PCR instrument. The qPCR reaction system is shown in Table 3 below, and the qPCR reaction conditions are shown in Table 4 below.
[0082] Table 3 qPCR plate sample ratio table
[0083]
[0084] Table 4 qPCR reaction conditions
[0085]
[0086] Unless otherwise specified, the following experiments were performed using qPCR in accordance with the reaction system, reaction conditions, and instructions in Section 2.1.
[0087] 2.2 Sample preparation
[0088] 2.2.1 Preparation of standard concentration samples and preparation of standard curve
[0089] Plasmid DNA containing HTLV-II fragments was gradiently diluted to obtain standard concentration samples, and qPCR detection was performed using the HTLV-II specific primers and probes shown in Table 1 until the lowest limit that could be stably detected was 0.2 fg / μL, which was set as the lower limit of detection (or the lower limit of quantification); the highest limit that could be detected was 200,000 / μL, which was set as the upper limit of detection (or the upper limit of quantification); concentrations higher than the upper limit of detection could also be detected, but it might affect the accuracy of quantitative detection or increase the possibility of false positive results. The standard concentration samples included a total of 7 standard concentration samples, as shown in Table 5 below. After qPCR detection with these standard concentration samples, the Ct value of the standard concentration sample was used as the ordinate (Y), and the logarithm of the concentration of the standard concentration sample was used as the abscissa (X), and a standard curve was fitted to obtain the standard curve regression equation and correlation coefficient. Two replicate wells were set for each sample.
[0090] Table 5 Standard concentration sample preparation table
[0091]
[0092] 2.2.2 Preparation of samples for method validation
[0093] Plasmid DNA containing HTLV-II fragments is diluted to different concentrations as plate quality control samples, precision accuracy samples, dilution linearity samples, and specificity samples. Plate quality control samples are used to evaluate whether a batch of PCR experiments is acceptable. The following is a table of various sample preparations:
[0094] Table 6 Plate quality control sample preparation table
[0095]
[0096] Table 7 Precision Accuracy Sample Preparation Table
[0097]
[0098] Table 8 Dilution linearity sample preparation table
[0099]
[0100] Table 9 Specific sample preparation table
[0101]
[0102] Among them, P-HQC, P-MQC, and P-LQC in Table 6 are quality control samples of high, medium, and low concentrations, respectively. In Table 7, LLOQ is the lower limit of quantification, LQC is the low concentration quality control, which is the same as P-LQC in Table 6, HQC is the high concentration quality control, which is the same as P-HQC in Table 6, MQC is the middle concentration quality control, which is the same as P-MQC in Table 6, and ULOQ is the upper limit of quantification.
[0103] 2.3 Precision and Accuracy Sample Testing
[0104] Plasmid DNA containing HTLV-II fragments was taken to prepare samples of five concentrations, including the lower limit of quantification (LLOQ), low concentration quality control (LQC), high concentration quality control (HQC), medium concentration quality control (MQC) and upper limit of quantification (ULOQ). The specific preparations are as shown in 2.2.2. qPCR detection was performed using the HTLV-II specific primers and probes shown in Table 1 to examine the intra-batch and inter-batch precision and accuracy of samples of different concentrations. The guidelines for validation of quantitative analysis methods for biological samples in the standard reference pharmacopoeia [19-21] were accepted, as shown in Table 10.
[0105] Table 10 Precision and accuracy test acceptance criteria
[0106]
[0107] The accuracy is RE%, and the calculation formula is: RE% = (C 测得 -C 理论 or C0) / C 理论 or C0×100%; wherein C0 is the initial concentration or theoretical concentration, which can be a known concentration or a concentration measured by other methods (the same below).
[0108] The precision is CV%, and the calculation formula is: CV% = standard deviation / mean value × 100% (the same below).
[0109] 2.4 Dilution linearity test
[0110] Use RNase / DNase-free water to gradient dilute the plasmid DNA containing HTLV-II fragments. After a certain ratio of dilution, perform qPCR with the primers and probes shown in Table 1. Set up two replicate wells for each group, and repeat each concentration three times. The acceptance criteria are as follows:
[0111] Table 11 Dilution Linearity Test Acceptance Criteria
[0112]
[0113] 2.5 Specificity detection
[0114] Plasmid DNA containing HTLV-II fragments was prepared as LQC samples, and qPCR experiments were performed using the primers and probes shown in Table 1 to calculate the RE% value. Two replicate wells were set for each group, and the acceptance criteria were as follows:
[0115] Table 12 Acceptance criteria for specificity tests
[0116]
[0117] 3. Experimental results
[0118] 3.1 Standard curve for HTLV-II proviral DNA qPCR detection
[0119] The qPCR amplification curve of the HTLV-II proviral DNA standard concentration sample is shown in Figure 3 The Ct value of each standard is used as the ordinate (Y), and the logarithm of the concentration of the standard curve is used as the abscissa (X) to fit the standard curve, such as Figure 4 shown.
[0120] The horizontal axis of the standard curve is still marked with the original value of the standard. The regression equation of the standard curve is y = -4.039 + 33.51, and the correlation coefficient R 2 =0.999.
[0121] 3.2 Precision, Accuracy and Sensitivity of HTLV-II Specific Primer qPCR Detection
[0122] qPCR detection was performed on LLOQ, LQC, HQC, MQC and ULOQ samples using the primers and probes shown in Table 1 to investigate the intra-batch and inter-batch precision and accuracy of samples of different concentrations. The amplification curves are shown in Figure 5 The results showed that the HTLV-II primers could stably detect 1fg of plasmid DNA containing HTLV-II fragments, and the intra-batch CV of the precision and accuracy samples was 4.3% to 30%, and the inter-batch CV was 3.6% to 19.4%, both between -75% and 150%; the intra-batch RE was -2.3% to 51.6%, and the inter-batch RE was -0.6% to 39.2%, which met the acceptance criteria (Table 13).
[0123] Table 13 Precision and accuracy test results
[0124]
[0125] To further verify the sensitivity of the reaction system, the sample with the lowest concentration of the standard curve was diluted 10-fold and 100-fold again, and qPCR detection was performed using the primers and probes in Table 1. The amplification curve is shown in Figure 6 As shown. It was found that the sample diluted 10 times could also be detected, that is, the sensitivity could reach 0.1fg / 5μL or 31.3copy. It was proved that the HTLV-II specific primer qPCR detection method has high precision and accuracy and high sensitivity.
[0126] To further verify the accuracy and effectiveness of the HTLV-II specific primers and qPCR experimental method, the plasmid DNA containing the HTLV-II fragment was diluted to 0.2 ng / μL with RNase / DNase-free water, and then diluted 20-fold, 400-fold, and 8000-fold with RNase / DNase-free water, respectively. As described in Section 2.4, TaqMan qPCR detection was performed with the primers and probes in Table 1. The amplification curve is shown in Figure 2. Figure 7 The results showed that after back-calculating the concentrations of the diluted samples from all concentration sources, the CVs were 0.4% to 3.7%, all ≤ 60%, proving that HTLV-II specific primer qPCR can accurately detect HTLV-II genomic DNA in the samples (Table 14).
[0127] Table 14 Dilution linearity test results
[0128]
[0129] 3.3 Specificity of HTLV-II specific primer qPCR detection method
[0130] The plasmid DNA containing the HTLV-II fragment was diluted to 0.2 ng / μL with RNase / DNase-free water, and then diluted to LQC (i.e., concentration of 2 fg / 5 μL) with RNase / DNase-free water. TaqMan qPCR detection was performed using the primers and probes in Table 1. The amplification curve is shown in Figure 8 The results showed that the LQC group could detect signals within the quantitative range, while the values of the RNase / DNase-free water group were all below the detection limit. The HTLV-II primers can specifically identify samples containing HTLV-II DNA (Table 15).
[0131] Table 15 Specificity test results
[0132]
[0133] Example 2 Detection of HTLV-II proviral DNA using ddPCR
[0134] 1. Experimental Methods
[0135] (1) Turn on the QX200 droplet reader and preheat for 30 minutes;
[0136] (2) Prepare a quantitative reaction system (20 μL):
[0137] ddPCR supermix (10 μL) + primer / probe (1 μL) + sample (plasmid, 9 μL)
[0138] (3) Droplet formation: Add 20 μL of reaction system and 70 μL of droplet generation oil (DG oil) to each row of the DG8 cartridge, cover with a rubber pad, and place in a droplet generator to form droplets.
[0139] (4) ddPCR detection: 40 μL of microdroplets were added to a 96-well plate, sealed and placed in a PCR instrument, and the reaction was carried out according to the program of 95°C, 10 min; 94°C, 30 s, 40 cycles; 98°C, 10 min. After the reaction, the 96-well plate was placed in a microdroplet reader, the Tm value and fluorescence signal were set, and the signal was read and analyzed.
[0140] (5) Result analysis: Numerical results are directly read on QuantaSoft.
[0141] 2. Experimental results
[0142] ddPCR has high sensitivity in detecting HTLV-II
[0143] In order to verify the applicability of HTLV-II primers to the ddPCR detection method, the constructed plasmid containing HTLV-II fragments (the plasmid used in the TaqMan qPCR method) was diluted 10 times in a gradient, and the diluted plasmids (S1 to S4) were used as samples for ddPCR detection. The numerical results were quantitatively calculated based on the proportion of positive droplets combined with the principle of Poisson distribution. Fig. 9 As shown, the primer-probe pair of the present invention can be used for ddPCR detection of HTLV-II primers, and has higher sensitivity than the TaqMan qPCR method, and can detect 0.39 copy / μL of HTLV-II provirus.
[0144] discuss
[0145] Primers and labeled probes designed and synthesized based on human HTLV-II specific sequences, combined with TaqMan qPCR experimental technology, can specifically detect whether HTLV-II genes exist in DNA of different types of samples. The experimental process is simple and convenient, with high accuracy, sensitivity and specificity.
[0146] HTLV-II can be transmitted through infected blood, semen, vaginal fluids, rectal secretions, breast milk and organ transplants, but mainly through intravenous injection. Currently, there is no effective treatment, so the only necessary prevention is through HTLV-II screening. Fundamentally, the cure for all infectious diseases lies in preventing infection. Infection with HTLV-II is a chronic and destructive disease, so it is necessary to screen personnel for relevant HTLV-II.
[0147] At present, in addition to traditional cytological examination, the detection of HTLV-II is mostly carried out by indirect immunofluorescence assay (IFA), gelatin particle agglutination reaction (GPA), enzyme-linked immunosorbent assay (ELISA) and protein blotting (WB). However, immunoassays based on antigens and antibodies have the disadvantages of cumbersome operation, difficult process standardization, low sensitivity, high false positive rate and high cost. Domestic related detection technologies and detection reagents are scarce, so new detection methods are needed to solve the above problems.
[0148] In the present invention, we designed and synthesized primers and probes of human-specific sequence HTLV-II, and used TaqManqPCR and ddPCR techniques to specifically detect the HTLV-II gene in the sample. Based on the verification of specificity, dilution linearity, precision and accuracy of primers and TaqManqPCR techniques, it is proved that this method can sensitively detect the HTLV-II genomic DNA of the sample. Unlike other detection methods with deficiencies or defects, our method has high accuracy and repeatability, and high sensitivity. Therefore, our HTLV-II primers and TaqMan PCR techniques can be used to detect HTLV-II in various samples and perform accurate quantification.
[0149] The HTLV-II specific primers of the present invention can also be applied to digital PCR detection technology, and have higher sensitivity, and are suitable for detecting precious samples, samples with less content or samples with complex components. Therefore, the method is particularly suitable for biological products for treatment and prevention, including but not limited to biosafety detection of products such as cells, antibodies and vaccines.
[0150] The implementation of the present invention is not limited to the above-mentioned embodiments. Without departing from the spirit and scope of the present invention, ordinary technicians in this field can make various changes and improvements to the present invention in form and detail, and these are considered to fall within the protection scope of the present invention.
[0151] References
[0152] 1. Kalyanaraman VS, Sarngadharan MG, Robertguroff M, et al. A newsubtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia[J]. Science, 1982, 218(4572): 571-573.
[0153] 2.Feuer G,Green P L.Comparative biology of human T-cell lymphotropicvirus type 1 (HTLV-1)and HTLV-2[J].Oncogene,2005,24(39):5996-6004.
[0154] 3.Matsuoka M.Human T-cell leukemia virus typeⅠ(HTLV-Ⅰ)infection and the onset of adult T-cell leukemia(ATL)[J].Retrovirology, 2005, 2(1):27.
[0155] 4.Tabei S Z.Human T Lypmphotrophic Virus(HTLV1)Related Diseases[J].iranian Red Crescent Medical Journal, 2011,13(6):374-376.
[0156] 5.Manns A,Wilks R J,Murphy E L,et al.A prospective study oftransmission by transfusion of HTLV-Ⅰand risk factors associated withseroconversion[J].international Journal of Cancer,1992,51(6):886-891.
[0157] 6.Hjelle B,Torrez-Martinez N,Mills R,et al.Chronic neurodegenerativedisease associated with HTLV-Ⅱinfection[J].Lancet,1992,339(8794):645-646.
[0158] 7.Dooneief G,Marlink R,Bell K,et al.Neurologic consequences of HTLV-Ⅱinfection in injection-drug users[J].Neurology,1996,46(6):1556.
[0159] 8.Murphy E L,Fridey J,Smith J W,et al.HTLV-associated myelopathy in acohort of HTLV-Ⅰand HTLV-Ⅱ-infected blood donors[J].Neurology,1997,48(2):315-320.
[0160] 9.Toro C,Berta Rodés,Bassani S,et al.Molecular epidemiology of HTLV-2infection among intravenous drug users in Spain[J].Journal of ClinicalVirology,2005,33(1):0-70.
[0161] 10.Lee H,Swanson P,Shorty V,et al.High rate of HTLV-Ⅱinfection inseropositive i.v. drug abusers in New Orleans[J].ScⅠence,1989,244(4903):471-475.
[0162] 11.Khabbaz R F,Hartel D,LaⅠrmore M,et al.Human T Lymphotropic VirusTypeⅡ (HTLV-Ⅱ)infection in a Cohort of New York intravenous Drug Users:AnOld infection?[J].Journal of infectious Diseases,1991,163(2):252-256.
[0163] 12.Lairmore M D,Jacobson S,Gracia F,et al.isolation of human T-celllymphotropic virus type 2 from Guaymiindians in Panama.[J].Proceedings of theNational Academy of Sciences, 1990,87(22):8840-8844.
[0164] 13.Heneine W,Kaplan J E,Gracia F,et al.HTLV-Ⅱendemicity amongGuaymiindians in Panama.[J].N Engl J Med,1991,324(8):565.
[0165] 14.Levine P H,Jacobson S,Elliott R,et al.HTLV-Ⅱinfection in Floridaindians[J].AiDS Research and Human Retroviruses,1993,9(2):123-127.
[0166] 15.Tajadini M,Panjehpour M,Javanmard S H.Comparison of SYBR Green andTaqMan methods in quantitative real-time polymerase chain reaction analysisof four adenosine receptor subtypes[J].Advanced Biomedical Research,3,1(2014-02-28),2014,3(1):85.
[0167] 16.Becker M,Nitsche A,Neumann C,et al.Sensitive PCR method for thedetection and real-time quantification of human cells in xenotransplantationsystems[J].BRITISH JOURNAL OF CANCER,2002,87(11):1328-1335.
[0168] 17.Sykes,P.J.,Neoh,S.H.,Brisco,M.J.,Hughes,E.,&Morley,A.A..(1992).Quantitation of targets for pcr by use of limiting dilution.BioTechniques,13(3),444-449.
[0169] 18.Dong,Lianhua,Meng,Ying,Wang,Jing,&Liu,Yingying..Evaluation ofdroplet digital pcr for characterizing plasmid reference material used forquantifying ammonia oxidizers and denitrifiers.Analytical&BioanalyticalChemistry,406(6),1701-1712.
[0170] 19.Lee HC,An SG,Lee HW,Park JS,Cha KS,Hong TJ,et al.Safety and effectof adipose tissue-derived stem cell implantation in patients with criticallimb ischemia:a pilot study.Circ J.2012;76(7):1750-60.
[0171] 20.Nguyen PK,Riegler J,Wu JC.Stem cell imaging:from bench tobedside.Cell Stem Cell. 2014;14(4):431-44.
[0172] 21.Wu Y,Zhao RC.The role of chemokines in mesenchymal stem cellhoming to myocardium.Stem Cell Rev.2012;8(1):243-50。
Claims
1. A primer and probe combination for specifically detecting HTLV-II proviral DNA, the primer pair comprising a forward primer and a reverse primer, wherein the forward primer is 5'-GCATCAAGCATTCTACCCATATAC -3' (SEQ ID NO: 1), and the reverse primer is 5'-GAAGGTTAGGACAGTCTAGTAGATA -3' (SEQ ID NO: 2); the sequence of the probe is 5'-CTGGTCGAGAGAACC -3' (SEQ ID NO: 3), the 5' end of the probe is labeled with a reporter fluorescent group, and the 3' end is labeled with a quenching group. 2 . The primer and probe combination according to claim 1 , wherein the reporter fluorescent group labeled at the 5′ end of the fluorescent probe is FAM, and the quencher group labeled at the 3′ end is NFQ-MGB or TAMRA.
3. Non-diagnostic use of the primer and probe combination according to claim 1 or 2 in detecting HTLV-II proviral DNA in a sample.
4. Use of the primer and probe combination according to claim 1 or 2 in the preparation of a reagent for detecting HTLV-II proviral DNA in a sample.
5. The use according to claim 3 or 4, wherein the detection is qPCR detection or droplet digital PCR (ddPCR) detection.
6. A kit for specifically detecting HTLV-II proviral DNA, the kit comprising a primer and probe combination according to claim 1 or 2.
7. The kit according to claim 6, further comprising any one or more reagents selected from qPCR reaction solution, water, HTLV-II proviral DNA standards, and reference substances, or any one or more reagents selected from ddPCR reaction solution and water.
8. A non-diagnostic method for detecting HTLV-II proviral DNA in a sample, comprising using the primer and probe combination according to claim 1 or 2 to perform qPCR detection or ddPCR detection on the sample DNA, and qualitatively or quantitatively detecting whether HTLV-II proviral DNA is present in the sample based on the qPCR or ddPCR detection results.
9. A non-diagnostic method for detecting HTLV-II proviral DNA in a sample, comprising the following steps: (1) Extract sample DNA; (2) using the primer and probe combination according to claim 1 or 2 to perform qPCR detection on HTLV-II proviral DNA standards and sample DNA, wherein the HTLV-II proviral DNA standards are samples of different given concentrations prepared with DNA containing HTLV-II proviral DNA fragments; (3) Use the qPCR test results of HTLV-II proviral DNA standard to make a standard curve and fit the linear equation, where R 2 ≥0.99; and the accuracy of each standard concentration is -75%~150%, to determine the lowest concentration that can be stably detected; (4) Result determination: If an obvious amplification curve appears in the qPCR results of the sample DNA, and the Ct value of the qPCR of the sample DNA is less than the Ct value at the lowest concentration point, it is a positive result, that is, HTLV-II proviral DNA is present in the sample; If there is no obvious amplification curve, or if there is an obvious amplification curve but the Ct value is greater than the Ct value at the lowest concentration point of the standard curve, it is a negative result, that is, there is no HTLV-II proviral DNA in the sample.
10. The method according to claim 9, wherein step (4) further comprises: The concentration of HTLV-II proviral DNA in the sample DNA was determined based on the Ct value of the sample DNA and the fitted standard curve.
11. A non-diagnostic method for detecting HTLV-II proviral DNA in a sample, comprising the following steps: (1) Extract sample DNA; (2) using the primer and probe combination according to claim 1 or 2 to perform qPCR detection on HTLV-II proviral DNA standards and sample DNA, wherein the HTLV-II proviral DNA standards are samples of different given concentrations prepared with DNA containing HTLV-II proviral DNA fragments; (3) Use the qPCR test results of HTLV-II proviral DNA standard to make a standard curve and fit the linear equation, where R 2 ≥0.99; and the accuracy of each standard concentration is -75%~150%, to determine the lowest concentration that can be stably detected; (4) Result determination: Determine the concentration of HTLV-II proviral DNA in the sample DNA based on the Ct value of the sample DNA and the fitted standard curve.
12. A non-diagnostic ddPCR method for detecting HTLV-II proviral DNA in a sample comprises the following steps: (1) Extract sample DNA; (2) using the primer and probe combination according to claim 1 or 2 to perform ddPCR detection on the sample DNA; (3) Result determination: Read the fluorescent signal and analyze it to quantify the HTLV-II proviral DNA copy number.
Citation Information
Patent Citations
Primer and method for detecting HTLV (human T-lymphotropic virus)-I and HTLV-II proviruses in same pipe
CN103898239A
B19 (Human parvovirus B19), HTLV (Human T-cell lymphotropic virus) and HEV (Hepatitis E virus) quadruple fluorescent PCR (polymerase chain reaction) quick hypersensitivity detection kit and application thereof
CN105886665A
Method for detecting human T-cell lymphotropic virus (HTLV) and special reagent kit thereof
CN107488746A
Specific primer and probe for detection of HTLV-I and HTLV-II and fluorescent quantitative PCR detection kit
CN108486281A
Kit for detecting HTLV strains and use thereof
US20120052501A1
